AMERICA'S CAR-MART INC (CRMT) Stock Fundamental Analysis

NASDAQ:CRMT • US03062T1051

21.68 USD
+0.38 (+1.78%)
Last: Feb 13, 2026, 12:41 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CRMT. CRMT was compared to 120 industry peers in the Specialty Retail industry. Both the profitability and financial health of CRMT have multiple concerns. CRMT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • CRMT had positive earnings in the past year.
  • CRMT had a negative operating cash flow in the past year.
  • CRMT had positive earnings in 4 of the past 5 years.
  • In the past 5 years CRMT always reported negative operating cash flow.
CRMT Yearly Net Income VS EBIT VS OCF VS FCFCRMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M -150M

1.2 Ratios

  • CRMT has a Return On Assets of -0.84%. This is comparable to the rest of the industry: CRMT outperforms 45.00% of its industry peers.
  • CRMT has a Return On Equity (-2.60%) which is comparable to the rest of the industry.
  • The Return On Invested Capital of CRMT (2.67%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CRMT is significantly below the industry average of 12.31%.
Industry RankSector Rank
ROA -0.84%
ROE -2.6%
ROIC 2.67%
ROA(3y)0.14%
ROA(5y)4.28%
ROE(3y)0.19%
ROE(5y)9.25%
ROIC(3y)3.44%
ROIC(5y)7.19%
CRMT Yearly ROA, ROE, ROICCRMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

1.3 Margins

  • In the last couple of years the Profit Margin of CRMT has declined.
  • The Operating Margin of CRMT (3.88%) is comparable to the rest of the industry.
  • CRMT's Operating Margin has declined in the last couple of years.
  • CRMT has a Gross Margin of 48.08%. This is in the better half of the industry: CRMT outperforms 75.00% of its industry peers.
  • CRMT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.88%
PM (TTM) N/A
GM 48.08%
OM growth 3Y-15.53%
OM growth 5Y-7.04%
PM growth 3Y-45.5%
PM growth 5Y-28.51%
GM growth 3Y2.42%
GM growth 5Y-0.01%
CRMT Yearly Profit, Operating, Gross MarginsCRMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

3

2. Health

2.1 Basic Checks

  • CRMT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, CRMT has more shares outstanding
  • The number of shares outstanding for CRMT has been increased compared to 5 years ago.
  • CRMT has a better debt/assets ratio than last year.
CRMT Yearly Shares OutstandingCRMT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
CRMT Yearly Total Debt VS Total AssetsCRMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • Based on the Altman-Z score of 1.63, we must say that CRMT is in the distress zone and has some risk of bankruptcy.
  • CRMT has a Altman-Z score of 1.63. This is in the lower half of the industry: CRMT underperforms 60.83% of its industry peers.
  • A Debt/Equity ratio of 1.61 is on the high side and indicates that CRMT has dependencies on debt financing.
  • CRMT has a worse Debt to Equity ratio (1.61) than 65.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Altman-Z 1.63
ROIC/WACC0.3
WACC8.85%
CRMT Yearly LT Debt VS Equity VS FCFCRMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • CRMT has a Current Ratio of 2.10. This indicates that CRMT is financially healthy and has no problem in meeting its short term obligations.
  • CRMT's Current ratio of 2.10 is fine compared to the rest of the industry. CRMT outperforms 80.00% of its industry peers.
  • CRMT has a Quick Ratio of 1.31. This is a normal value and indicates that CRMT is financially healthy and should not expect problems in meeting its short term obligations.
  • CRMT has a Quick ratio of 1.31. This is amongst the best in the industry. CRMT outperforms 82.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 1.31
CRMT Yearly Current Assets VS Current LiabilitesCRMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 108.98% over the past year.
  • The earnings per share for CRMT have been decreasing by -30.02% on average. This is quite bad
  • The Revenue has been growing slightly by 2.07% in the past year.
  • Measured over the past years, CRMT shows a quite strong growth in Revenue. The Revenue has been growing by 13.31% on average per year.
EPS 1Y (TTM)108.98%
EPS 3Y-55.08%
EPS 5Y-30.02%
EPS Q2Q%-229.17%
Revenue 1Y (TTM)2.07%
Revenue growth 3Y5.17%
Revenue growth 5Y13.31%
Sales Q2Q%0.84%

3.2 Future

  • The Earnings Per Share is expected to grow by 48.67% on average over the next years. This is a very strong growth
  • CRMT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.09% yearly.
EPS Next Y-115.22%
EPS Next 2Y56.37%
EPS Next 3Y48.67%
EPS Next 5YN/A
Revenue Next Year5.03%
Revenue Next 2Y4.84%
Revenue Next 3Y6.09%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRMT Yearly Revenue VS EstimatesCRMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CRMT Yearly EPS VS EstimatesCRMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 144.53, the valuation of CRMT can be described as expensive.
  • The rest of the industry has a similar Price/Earnings ratio as CRMT.
  • When comparing the Price/Earnings ratio of CRMT to the average of the S&P500 Index (27.67), we can say CRMT is valued expensively.
  • A Price/Forward Earnings ratio of 7.15 indicates a rather cheap valuation of CRMT.
  • Based on the Price/Forward Earnings ratio, CRMT is valued cheaper than 95.83% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.69. CRMT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 144.53
Fwd PE 7.15
CRMT Price Earnings VS Forward Price EarningsCRMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRMT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.37
CRMT Per share dataCRMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

  • CRMT's earnings are expected to grow with 48.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y56.37%
EPS Next 3Y48.67%

0

5. Dividend

5.1 Amount

  • No dividends for CRMT!.
Industry RankSector Rank
Dividend Yield 0%

AMERICA'S CAR-MART INC

NASDAQ:CRMT (2/13/2026, 12:41:03 PM)

21.68

+0.38 (+1.78%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-04
Earnings (Next)02-25
Inst Owners86.53%
Inst Owner Change-0.74%
Ins Owners15.06%
Ins Owner Change-0.05%
Market Cap179.51M
Revenue(TTM)1.39B
Net Income(TTM)-14.45M
Analysts80
Price Target33.66 (55.26%)
Short Float %14.31%
Short Ratio6.47
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.01
Dividend Growth(5Y)-1.73%
DP-0.14%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-116.99%
Min EPS beat(2)-175.75%
Max EPS beat(2)-58.22%
EPS beat(4)2
Avg EPS beat(4)6.27%
Min EPS beat(4)-175.75%
Max EPS beat(4)229.77%
EPS beat(8)2
Avg EPS beat(8)-54.08%
EPS beat(12)2
Avg EPS beat(12)-102.37%
EPS beat(16)3
Avg EPS beat(16)-82.58%
Revenue beat(2)1
Avg Revenue beat(2)-1.57%
Min Revenue beat(2)-6.84%
Max Revenue beat(2)3.71%
Revenue beat(4)3
Avg Revenue beat(4)2.04%
Min Revenue beat(4)-6.84%
Max Revenue beat(4)8.15%
Revenue beat(8)5
Avg Revenue beat(8)-0.99%
Revenue beat(12)7
Avg Revenue beat(12)-0.17%
Revenue beat(16)11
Avg Revenue beat(16)1.47%
PT rev (1m)-7.04%
PT rev (3m)-16.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-67.69%
EPS NY rev (1m)0%
EPS NY rev (3m)-117.29%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-1.55%
Revenue NY rev (1m)-0.42%
Revenue NY rev (3m)-1.05%
Valuation
Industry RankSector Rank
PE 144.53
Fwd PE 7.15
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B 0.32
P/tB 0.34
EV/EBITDA 15.37
EPS(TTM)0.15
EY0.69%
EPS(NY)3.03
Fwd EY13.99%
FCF(TTM)-1.35
FCFYN/A
OCF(TTM)-1.02
OCFYN/A
SpS167.56
BVpS67.08
TBVpS64.22
PEG (NY)N/A
PEG (5Y)N/A
Graham Number15.05
Profitability
Industry RankSector Rank
ROA -0.84%
ROE -2.6%
ROCE 3.39%
ROIC 2.67%
ROICexc 2.89%
ROICexgc 2.94%
OM 3.88%
PM (TTM) N/A
GM 48.08%
FCFM N/A
ROA(3y)0.14%
ROA(5y)4.28%
ROE(3y)0.19%
ROE(5y)9.25%
ROIC(3y)3.44%
ROIC(5y)7.19%
ROICexc(3y)3.46%
ROICexc(5y)7.23%
ROICexgc(3y)3.51%
ROICexgc(5y)7.31%
ROCE(3y)4.38%
ROCE(5y)9.16%
ROICexgc growth 3Y-20.68%
ROICexgc growth 5Y-14.67%
ROICexc growth 3Y-20.88%
ROICexc growth 5Y-14.71%
OM growth 3Y-15.53%
OM growth 5Y-7.04%
PM growth 3Y-45.5%
PM growth 5Y-28.51%
GM growth 3Y2.42%
GM growth 5Y-0.01%
F-Score4
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Debt/EBITDA 14.49
Cap/Depr 34.6%
Cap/Sales 0.2%
Interest Coverage 0.77
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.1
Quick Ratio 1.31
Altman-Z 1.63
F-Score4
WACC8.85%
ROIC/WACC0.3
Cap/Depr(3y)178.38%
Cap/Depr(5y)233.56%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)108.98%
EPS 3Y-55.08%
EPS 5Y-30.02%
EPS Q2Q%-229.17%
EPS Next Y-115.22%
EPS Next 2Y56.37%
EPS Next 3Y48.67%
EPS Next 5YN/A
Revenue 1Y (TTM)2.07%
Revenue growth 3Y5.17%
Revenue growth 5Y13.31%
Sales Q2Q%0.84%
Revenue Next Year5.03%
Revenue Next 2Y4.84%
Revenue Next 3Y6.09%
Revenue Next 5YN/A
EBIT growth 1Y-20.05%
EBIT growth 3Y-11.16%
EBIT growth 5Y5.33%
EBIT Next Year344.53%
EBIT Next 3Y95.69%
EBIT Next 5YN/A
FCF growth 1Y91.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y92.94%
OCF growth 3YN/A
OCF growth 5YN/A

AMERICA'S CAR-MART INC / CRMT FAQ

Can you provide the ChartMill fundamental rating for AMERICA'S CAR-MART INC?

ChartMill assigns a fundamental rating of 3 / 10 to CRMT.


What is the valuation status for CRMT stock?

ChartMill assigns a valuation rating of 4 / 10 to AMERICA'S CAR-MART INC (CRMT). This can be considered as Fairly Valued.


Can you provide the profitability details for AMERICA'S CAR-MART INC?

AMERICA'S CAR-MART INC (CRMT) has a profitability rating of 3 / 10.


What is the valuation of AMERICA'S CAR-MART INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for AMERICA'S CAR-MART INC (CRMT) is 144.53 and the Price/Book (PB) ratio is 0.32.


What is the financial health of AMERICA'S CAR-MART INC (CRMT) stock?

The financial health rating of AMERICA'S CAR-MART INC (CRMT) is 3 / 10.